The largest investment in an Israeli company during April 2018 was $70 million raised by Caesarea-based V-Wave, which is about to start multicenter clinical trials of its minimally invasive implanted interatrial shunt device for treating patients with severe symptomatic heart failure. The round was led by Deerfield Management with participation of...
Continue Reading >>










